Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Feb. 28, 2018
Feb. 28, 2017
Cash flows used in operating activities    
Net loss for the period $ (1,957,091) $ (865,535)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 122,562 36,642
Depreciation and amortization 837 744
Inventory write-off 8,984 3,925
Shares issued for services 183,426 59,760
Warrants issued for services 717,880 220,528
Change in working capital:    
Accounts and other receivables (142,992) 13,953
Inventory (4,336) (12,568)
Prepaid expenses (27,156) 18,813
Accounts payable and accrued liabilities 30,873 (47,047)
Due to related parties (37,096) (30,756)
Unearned revenue (17,083) 12,469
Net cash used in operating activities (1,121,192) (589,072)
Cash flows used in investing activities    
Investment in Poviva (70,000) 0
Patent (32,042) (9,699)
Net cash used in investing activities (102,042) (9,699)
Cash flows from financing activities    
Repayment of loan to a related party 0 (18,000)
Proceeds from issuance of equity 1,007,591 1,046,995
Net cash from financing activities 1,007,591 1,028,995
Increase (decrease) in cash (215,643) 430,224
Cash, beginning of period 2,533,337 93,409
Cash, end of period 2,317,694 523,633
Supplemental information on cash flows:    
Interest paid in cash 0 3,306
Common shares issued to settle accounts payable 12,000 17,000
Stock based compensation recognized in prepaid expenses 0 19,075
Reclassification of NCI to additional paid-in capital on acquisition $ 238,476 $ 0